Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This study is designed to evaluate the efficacy, safety, and tolerability of USL261 compared with that of intranasal (IN) placebo for the treatment of intermittent bouts of increased seizure activity.
Epistemonikos ID: 56a2e61d09bb320a6a43e9f0716e6d2fc16f290a
First added on: May 11, 2024